PATHFINDER: Interim analysis of avapritinib (ava) in patients (pts) with advanced systemic mastocytosis (AdvSM). DeAngelo, D. J., Reiter, A., Radia, D., Deininger, M. W., George, T. I., Panse, J., Vannucchi, A. M., Jentzsch, M., Alvarez-Twose, I., Mital, A., Hermine, O., Dybedal, I., Hexner, E. O., Hicks, L. K., Span, L., Mesa, R., Bose, P., Pettit, K. M., Heaney, M. L., Oh, S., Sen, J., Lin, H., Mar, B. G., Gotlib, J. AMER ASSOC CANCER RESEARCH. 2021

View details for Web of Science ID 000680263501007